Murcko Mark 4
4 · Relay Therapeutics, Inc. · Filed Jun 1, 2023
Insider Transaction Report
Form 4
Murcko Mark
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-31+66,055→ 66,055 totalExercise: $11.14Exp: 2033-05-30→ Common Stock (66,055 underlying)
Footnotes (1)
- [F1]This option was granted on May 31, 2023 with respect to 66,055 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.